Loading
Latest filing published 02 Apr 2024 for Elite Pharmaceuticals INC.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Nasrat A. Hakim is a declared insider of Elite Pharmaceuticals Inc, with filings sourced from SEC (Form 4). Between 7 February 2014 and 29 March 2024, the trades on record add up to 15 filings.
Purchases make up the whole of the open-market record (2 purchases, €170k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 6 share grants and 1 option exercise.
The latest filing, published on 2 April 2024, reports a share grant in Elite Pharmaceuticals Inc. The latest purchase dates back some time: it was published 4,408 days ago, on 29 September 2014. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations